MIAMI BEACH, Fla. – A study released march 28, 2023 today has shown promise in the treatment of endometrial cancer.
A clinical trial, led in part by Dr. Brian Slomovitz, Director of Gynecologic Oncology at Mt. Sinai Medical Center, evaluated the benefits of combining immunotherapy with chemotherapy in select patients.
“This study that we performed looked at the addition of immunotherapy to chemotherapy in the first line setting and we found positive results. We found in a sub group of patients, patients are living much longer and statistically significantly longer than chemotherapy alone. And there’s also statistical significance in overall survival in a subset of patients,” he said.
Slomovitz said the data is strong enough to consider immunotherapy in the treatment of all women with endometrial cancer.
And for adults who face difficulty exercising regularly, a recent study offers encouragement.
Past research has shown that people who walk regularly, an average of eight thousand steps a day, experience lower overall mortality.
This latest cohort study involved over three thousand US Adults age twenty and older.
It found that participants who took eight thousand steps on just one or two days during the week also reduced their mortality risk from all causes including cardiovascular disease.
The protective association plateaued at three days per week.
And according to a review published March 28, 2023, British researchers said the important heart health benefits of weight loss are sustained even if some of the weight comes back.
The study found that participants in weight loss programs still had lower blood pressure and better cholesterol and blood sugar numbers even if they regained a little back.
The benefit diminished with added weight gain but the findings suggest that weight loss at any point in life has a cardiovascular and diabetes benefit in the long run.